Works about HYPOPHOSPHATEMIA


Results: 878
    1
    2

    Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).

    Published in:
    Journal of Neuro-Oncology, 2019, v. 143, n. 3, p. 573, doi. 10.1007/s11060-019-03194-z
    By:
    • Jaeckle, Kurt A.;
    • Anderson, S. K.;
    • Twohy, Erin L.;
    • Dixon, Jesse G.;
    • Giannini, Caterina;
    • Jenkins, Robert;
    • Egorin, Merrill J.;
    • Sarkaria, Jann N.;
    • Brown, Paul D.;
    • Flynn, P. J.;
    • Schwerkoske, John;
    • Buckner, Jan C.;
    • Galanis, Evanthia
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11

    O-13 Parathyroid carcinoma - a rare and challenging entity.

    Published in:
    JCEM Case Reports, 2024, v. 2, p. 1, doi. 10.1210/jcemcr/luad146.014
    By:
    • Martins, João Dinis;
    • Pina, Henrique;
    • Féria, Rita Palma;
    • Moules, Pedro;
    • Miranda, Pedro;
    • Gomes, Catarina;
    • Guerra, Sílvia;
    • Marques, Joana;
    • Ferreira, Marisa Peralta;
    • Valadas, Cristina
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20

    A review of select minerals influencing the haematopoietic process.

    Published in:
    Nutrition Research Reviews, 2018, v. 31, n. 2, p. 267, doi. 10.1017/S0954422418000112
    By:
    • Oliveira, Dalila Cunha;
    • Nogueira-Pedro, Amanda;
    • Santos, Ed Wilson;
    • Hastreiter, Araceli;
    • Silva, Graziela Batista;
    • Borelli, Primavera;
    • Fock, Ricardo Ambrósio
    Publication type:
    Article
    21
    22
    23
    24
    25
    26

    X-Linked Hypophosphatemia: Does Targeted Therapy Modify Dental Impairment?

    Published in:
    Journal of Clinical Medicine, 2023, v. 12, n. 24, p. 7546, doi. 10.3390/jcm12247546
    By:
    • Abdullah, Anusha;
    • Wuersching, Sabina Noreen;
    • Kollmuss, Maximilian;
    • Poxleitner, Philipp;
    • Dewenter, Ina;
    • Brandenburg, Leonard Simon;
    • Steybe, David;
    • Fegg, Florian Nepomuk;
    • Smolka, Wenko;
    • Otto, Sven;
    • Obermeier, Katharina Theresa
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Regorafenib in Patients with Antiangiogenic‐Naïve and Chemotherapy‐Refractory Advanced Colorectal Cancer: Results from a Phase IIb Trial.

    Published in:
    Oncologist, 2019, v. 24, n. 9, p. 1180, doi. 10.1634/theoncologist.2019-0067
    By:
    • Riechelmann, Rachel P.;
    • Leite, Luiz S.;
    • Bariani, Giovanni M.;
    • Glasberg, Joao;
    • Rivelli, Thomas G.;
    • da Fonseca, Leonardo Gomes;
    • Nebuloni, Daniela R.;
    • Braghiroli, Maria I.;
    • Queiroz, Marcelo A.;
    • Isejima, Alice M.;
    • Kappeler, Christian;
    • Kikuchi, Luciana;
    • Hoff, Paulo M.
    Publication type:
    Article
    36

    Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single‐Arm, Open‐Label Phase IIIb CONSIGN Study.

    Published in:
    Oncologist, 2019, v. 24, n. 2, p. 185, doi. 10.1634/theoncologist.2018-0072
    By:
    • Van Cutsem, Eric;
    • Martinelli, Erika;
    • Cascinu, Stefano;
    • Sobrero, Alberto;
    • Banzi, Maria;
    • Seitz, Jean‐François;
    • Barone, Carlo;
    • Ychou, Marc;
    • Peeters, Marc;
    • Brenner, Baruch;
    • Hofheinz, Ralf Dieter;
    • Maiello, Evaristo;
    • André, Thierry;
    • Spallanzani, Andrea;
    • Garcia‐Carbonero, Rocio;
    • Arriaga, Yull E.;
    • Verma, Udit;
    • Grothey, Axel;
    • Kappeler, Christian;
    • Miriyala, Ashok
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50